US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist
  • 4.860
  • +0.200+4.29%
Close Mar 31 16:00 ET
  • 4.958
  • +0.098+2.02%
Pre 08:03 ET
264.08MMarket Cap-1.35P/E (TTM)

About Emergent BioSolutions Company

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Company Profile

SymbolEBS
Company NameEmergent BioSolutions
Listing DateOct 2, 2009
Issue Price12.50
Founded1998
CEOMr. Joseph C. Papa
MarketNYSE
Employees900
Fiscal Year Ends12-31
Address300 Professional Drive,Suite 400
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20879
Phone1-240-631-3200

Company Executives

  • Name
  • Position
  • Salary
  • Joseph C. Papa
  • Director, President and Chief Executive Officer
  • 5.86M
  • Simon C. Lowry, M.D.
  • Chief Medical Officer and Head of Research and Development
  • --
  • Richard S. Lindahl
  • Principal Accounting Officer, Executive Vice President, Chief Financial Officer and Treasurer
  • 2.31M
  • Jessica Perl
  • Senior Vice President, General Counsel and Corporate Secretary
  • --
  • Coleen Glessner
  • Executive Vice President, Quality and Ethics and Compliance
  • 2.05M
  • William Hartzel
  • Senior Vice President, Manufacturing and Bioservice
  • --
  • Paul Williams
  • Senior Vice President, Products Business
  • 1.68M
  • Dr. Zsolt Harsanyi,PhD
  • Chairman of the Board
  • 420.00K
  • Sujata Dayal
  • Independent Director
  • 275.00K
  • Ronald B. Richard
  • Independent Director
  • 275.00K
  • Neal F. Fowler
  • Independent Director
  • 270.00K
  • Marvin L. White
  • Independent Director
  • 290.00K
  • Keith A. Katkin
  • Independent Director
  • 285.00K
  • Donald W. DeGolyer
  • Independent Director
  • 265.00K
  • Dr. Louis W. Sullivan, M.D.
  • Independent Director
  • 275.00K
  • Dr. Kathryn C. Zoon, PhD
  • Independent Director
  • 285.00K

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More